
Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis
Chapel Hill, NC, April 7, 2022 – Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare,...